4
Presence of Particulate Matter; identified as glass
- Agency
- FDA Drug
- Recall date
- Dec 21, 2023
- Status
- Ongoing
- Company
- Pfizer Inc.
1. What product was recalled?
4
4.2% Sodium Bicarbonate Injection, USP 5 mEq/10 mL (0.5 mEq/mL), Glass ABBOJECT Unit of Use Syringe, For Intravenous Use, Rx Only, 10 mL Syringe per Carton, Hospira, Inc., Lake Forst, IL 60045, NDC 0409-5534-24 (carton), 0409-5534-14 (case).
Quantity: 34000 Cartons
Code or lot text: Lot GX1542, Exp. 01/01/2025
- LOT
- Exp. 01/01/2025
- LOT
- Lot GX1542
- RECALL-NUMBER
- D-0233-2024
2. Is my exact product affected?
Compare every printed identifier. A matching value can indicate that your product is included.
3. What is the hazard?
Presence of Particulate Matter; identified as glass
4. What should I do now?
Follow the FDA recall notice and contact the recalling company for current instructions.
5. Where was it sold or distributed?
Nationwide
View source evidence for state distribution
- Puerto Rico: Nationwide in the USA and Puerto Rico.
6. Were injuries or illnesses reported?
No separate injury or illness statement was present in the normalized record. Check the official source for the latest report.
7. What remedy is available?
Follow the FDA recall notice and contact the recalling company for current instructions.
8. Is the recall active or closed?
The source status is Ongoing. Recall Index urgency is urgent, which is a separate deterministic site label.
9. When was the information checked?
Last checked .
- created
10. Where is the official source?
Open the official FDA Drug source
Recall Index normalizes public source data for easier checking. Source agencies remain authoritative. Confirm identifiers and instructions at the official source.